查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1954260

長讀長定序市場分析及至2035年預測：依類型、產品、服務、技術、應用、最終用戶、組件、設備、流程、部署類型及模式分類

Long Read Sequencing Market Analysis and Forecast to 2035: Type, Product, Services, Technology, Application, End User, Component, Device, Process, Installation Type
出版日期: | 出版商: Global Insight Services | 英文 334 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

預計長讀長定序市場將從2024年的24億美元成長到2034年的91億美元，複合年成長率約為12.2%。長讀長定序市場涵蓋了先進的基因測序技術，能夠讀取長DNA或RNA片段，從而提供對複雜遺傳結構的全面洞察。精準醫療、個人化醫療和基因組研究的需求是推動該市場成長的主要因素。其主要應用包括罕見疾病診斷、癌症基因組學和農業生物技術。創新的重點在於提高定序的準確性、速度和成本效益，以滿足​​研究人員和醫療保健提供者對詳細遺傳資訊的需求。

受基因組研究和個人化醫療發展趨勢的推動，長讀長定序市場正經歷顯著成長。其中，耗材細分市場成長最快，這主要得益於定序過程中對試劑和試劑盒的持續需求。其次是設備細分市場，定序平台的不斷創新提高了數據準確性和通量。在各個子細分市場中，單分子即時定序憑藉其更長的讀長和更高的準確性主導。奈米孔定序因其便攜性和即時數據生成能力而備受關注，成為第二大成長細分市場。服務區隔也呈現強勁成長，這主要得益於科研機構和製藥公司對定序服務的外包需求不斷增加。隨著對全面基因組資訊的需求日益成長，定序技術和生物資訊解決方案的持續發展將帶來新的機會並推動未來的進步，預計市場將進一步擴張。

市場區隔
類型 單分子即時定序、奈米孔定序、合成長讀長定序
產品 設備、耗材和軟體
服務 定序服務、生物資訊服務
科技 SMRT定序、奈米孔定序
目的 全基因組定序、表觀遺傳學、轉錄組學、總體基因體學、結構突變檢測
最終用戶 學術研究機構、製藥和生物技術公司、醫院和診所
成分 硬體和軟體
流程 樣品製備、定序與數據分析
實施表格 本機部署、雲端部署
模式 研究模式、臨床模式

長讀長定序市場競爭激烈，各廠商都試圖透過極具競爭力的價格策略和創新產品推出來擴大市場佔有率。快速的技術創新正在加速尖端定序平台的普及應用。這些創新旨在提高定序的準確性和速度，以滿足日益成長的全面基因組分析需求。同時，價格競爭仍然激烈，各公司都在努力提供兼顧成本效益和品質的解決方案。旨在拓展產品系列和增強全球影響力的策略聯盟和夥伴關係進一步加劇了這種競爭格局。在競爭基準方面，許多主要廠商都在利用自身的技術能力來維持競爭優勢。監管環境至關重要，嚴格的指導方針影響產品開發和打入市場策略。北美和歐洲憑藉健全的法規結構和高普及率處於領先地位。亞太地區正崛起為一個充滿潛力的市場，其特點是醫療基礎設施和研究舉措投資不斷增加。預計在定序技術進步和對個人化醫療日益重視的推動下，亞太市場將實現顯著成長。儘管監管合規和高營運成本等挑戰依然存在，但創新和市場擴張的潛力依然巨大。

主要趨勢和促進因素：

長讀長定序市場正經歷強勁成長，這主要得益於多種動態趨勢和促進因素。其中一個關鍵趨勢是對全面基因組分析的需求日益成長，而長讀長定序技術恰好能夠滿足這項需求。這些技術能夠提供無與倫比的準確性和洞察力，尤其是在複雜的基因組區域，推動了其在各種研究和臨床環境中的應用。此外，生物資訊學和數據分析的進步也提升了長讀長定序的效用。這些進步使得資料處理和解讀更加高效，使研究人員更容易獲得這些技術，並從中受益。同時，定序成本的下降也使小規模機構和新興市場能夠投資於這些前沿解決方案，從而提高了定序技術的普及度。個人化醫療的日益普及也推動了市場的發展，因為詳細的基因資訊對於個人化治療至關重要。長讀長定定序能夠提供全面的基因組訊息，使其成為這一新興領域的重要工具。此外，學術機構和產業界的合作正在促進創新並拓展應用領域，進一步加速市場成長。遺傳疾病的日益增加以及對精準診斷工具的需求，是推動長讀長定序市場向前發展的其他促進因素。

目錄

第1章執行摘要

第2章 市場亮點

第3章 市場動態

  • 宏觀經濟分析
  • 市場趨勢
  • 市場促進因素
  • 市場機遇
  • 市場限制
  • 複合年均成長率：成長分析
  • 影響分析
  • 新興市場
  • 技術藍圖
  • 戰略框架

第4章 細分市場分析

  • 市場規模及預測：依類型
    • 單分子即時定序
    • 奈米孔定序
    • 合成長讀定序
  • 市場規模及預測：依產品分類
    • 裝置
    • 消耗品
    • 軟體
  • 市場規模及預測：依服務分類
    • 定序服務
    • 生物資訊服務
  • 市場規模及預測：依技術分類
    • SMRT定序
    • 奈米孔定序
  • 市場規模及預測：依應用領域分類
    • 全基因測序
    • 表觀遺傳學
    • 轉錄組學
    • 總體基因體學
    • 結構突變檢測
  • 市場規模及預測：依最終用戶分類
    • 學術研究機構
    • 製藥和生物技術公司
    • 醫院和診所
  • 市場規模及預測：依組件分類
    • 硬體
    • 軟體
  • 市場規模及預測：依製程分類
    • 樣品製備
    • 定序
    • 數據分析
  • 市場規模及預測：依實施類型分類
    • 本地部署
    • 基於雲端的
  • 市場規模及預測：按模式
    • 研究模式
    • 臨床模式

第5章 區域分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲地區
  • 亞太地區
    • 中國
    • 印度
    • 韓國
    • 日本
    • 澳洲
    • 台灣
    • 亞太其他地區
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 義大利
    • 其他歐洲地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 撒哈拉以南非洲
    • 其他中東和非洲地區

第6章 市場策略

  • 需求與供給差距分析
  • 貿易和物流限制
  • 價格、成本和利潤率趨勢
  • 市場滲透率
  • 消費者分析
  • 法規概述

第7章 競爭訊息

  • 市場定位
  • 市場占有率
  • 競爭基準
  • 主要企業的策略

第8章 公司簡介

  • Pacific Biosciences
  • Oxford Nanopore Technologies
  • Genapsys
  • Stratos Genomics
  • Element Biosciences
  • Quantum-Si
  • Dovetail Genomics
  • Genome Transcriptome Facility of Bordeaux
  • Seq LL
  • Bionano Genomics
  • Tecan Genomics
  • Arima Genomics
  • 10x Genomics
  • Gencove
  • Twist Bioscience
  • Bio Skryb Genomics
  • Nu GEN Technologies
  • Longas Technologies
  • Loop Genomics
  • Base Genomics

第9章：關於我們

簡介目錄
Product Code: GIS10506

Long Read Sequencing Market is anticipated to expand from $2.4 billion in 2024 to $9.1 billion by 2034, growing at a CAGR of approximately 12.2%. The Long Read Sequencing Market encompasses advanced genomic sequencing technologies that enable the reading of long DNA or RNA fragments, providing comprehensive insights into complex genetic structures. This market is driven by the demand for precision medicine, personalized healthcare, and research in genomics. Key applications include rare disease diagnosis, cancer genomics, and agricultural biotechnology. Innovations focus on improving accuracy, speed, and cost-effectiveness, addressing the needs of researchers and healthcare providers for detailed genetic information.

The Long Read Sequencing Market is experiencing significant growth, fueled by advancements in genomic research and personalized medicine. Within this market, the consumables segment is the top performer, driven by the recurring need for reagents and kits in sequencing processes. Instruments follow closely, with continuous innovations in sequencing platforms enhancing data accuracy and throughput. Among the sub-segments, single-molecule real-time sequencing is leading due to its capability to provide longer read lengths and higher accuracy. Nanopore sequencing is the second highest performing sub-segment, gaining traction for its portability and real-time data generation. The services segment is also witnessing robust growth, as outsourcing of sequencing services becomes more prevalent among research institutions and pharmaceutical companies. As the demand for comprehensive genomic insights rises, the market is poised for further expansion, with ongoing developments in sequencing technologies and bioinformatics solutions promising to unlock new opportunities and drive future advancements.

Market Segmentation
TypeSingle-Molecule Real-Time Sequencing, Nanopore Sequencing, Synthetic Long Read Sequencing
ProductInstruments, Consumables, Software
ServicesSequencing Services, Bioinformatics Services
TechnologySMRT Sequencing, Nanopore Sequencing
ApplicationWhole Genome Sequencing, Epigenetics, Transcriptomics, Metagenomics, Structural Variation Detection
End UserAcademic and Research Institutions, Pharmaceutical and Biotechnology Companies, Hospitals and Clinics
ComponentHardware, Software
ProcessLibrary Preparation, Sequencing, Data Analysis
DeploymentOn-Premise, Cloud-Based
ModeResearch Mode, Clinical Mode

The Long Read Sequencing Market is characterized by a diverse array of players, each vying for increased market share through competitive pricing strategies and innovative product launches. The market is witnessing a surge in technological advancements, propelling the introduction of cutting-edge sequencing platforms. These innovations are designed to enhance accuracy and speed, catering to the growing demand for comprehensive genomic analysis. Meanwhile, pricing dynamics remain competitive, with companies striving to offer cost-effective solutions without compromising on quality. This competitive landscape is further intensified by strategic collaborations and partnerships aimed at expanding product portfolios and enhancing global reach. In terms of competition benchmarking, several key players are leveraging their technological prowess to maintain a competitive edge. The regulatory landscape is pivotal, with stringent guidelines shaping product development and market entry strategies. North America and Europe are at the forefront, driven by robust regulatory frameworks and high adoption rates. Asia-Pacific is emerging as a lucrative market, characterized by increasing investments in healthcare infrastructure and research initiatives. The market is poised for substantial growth, driven by advancements in sequencing technologies and the growing emphasis on personalized medicine. Challenges such as regulatory compliance and high operational costs persist, yet the potential for innovation and market expansion remains significant.

Geographical Overview:

The Long Read Sequencing Market is witnessing robust expansion across various regions, each presenting unique growth opportunities. North America leads this market, buoyed by extensive research initiatives and substantial funding. The presence of major biotechnology firms further accelerates market development. Europe follows, with a strong focus on genomics and personalized medicine, attracting significant investments and fostering innovation. In Asia Pacific, the market is growing rapidly, driven by technological advancements and increased healthcare expenditure. Countries like China and India are emerging as key players due to their expanding research capabilities and supportive government policies. Latin America is gaining traction, with rising investments in genomic research and a growing interest in precision medicine. The Middle East & Africa are also showing promise, with increasing awareness and adoption of advanced sequencing technologies. These regions are recognizing the potential of long read sequencing in advancing healthcare and research, thereby presenting lucrative opportunities for market players.

The global imposition of tariffs on biotechnology and sequencing equipment is influencing the Long Read Sequencing Market, particularly in East Asia. Japan and South Korea are navigating increased costs by fostering innovation in sequencing technologies and enhancing domestic capabilities. China's strategic pivot towards self-reliance is evident in its substantial investment in homegrown sequencing technology, mitigating impacts from Western trade barriers. Taiwan, while a pivotal player in semiconductor manufacturing, faces geopolitical vulnerabilities, potentially disrupting its supply chain continuity. The parent genomics market is witnessing robust growth, driven by advancements in personalized medicine and bioinformatics. By 2035, the market is poised for expansion, contingent on geopolitical stability and supply chain resilience. Meanwhile, Middle Eastern conflicts pose risks to global energy prices, indirectly affecting operational costs across the biotechnology sector.

Key Trends and Drivers:

The Long Read Sequencing Market is experiencing robust growth, propelled by several dynamic trends and drivers. One significant trend is the increasing demand for comprehensive genomic analysis, which long read sequencing technologies can uniquely provide. These technologies offer unparalleled accuracy and insight, particularly in complex genomic regions, driving their adoption in various research and clinical settings. Additionally, advancements in bioinformatics and data analytics are enhancing the utility of long read sequencing. They enable more efficient data processing and interpretation, making these technologies more accessible and valuable to researchers. Furthermore, decreasing costs associated with sequencing are democratizing access, allowing smaller institutions and emerging markets to invest in these cutting-edge solutions. The market is also driven by the growing emphasis on personalized medicine, where detailed genetic information is crucial for tailoring treatments. Long read sequencing's ability to deliver comprehensive genomic insights positions it as a critical tool in this evolving field. Moreover, collaborations between academic institutions and industry players are fostering innovation and expanding application areas, further fueling market growth. The increasing prevalence of genetic disorders and the need for precise diagnostic tools are additional drivers propelling the long read sequencing market forward.

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Services
  • 2.4 Key Market Highlights by Technology
  • 2.5 Key Market Highlights by Application
  • 2.6 Key Market Highlights by End User
  • 2.7 Key Market Highlights by Component
  • 2.8 Key Market Highlights by Process
  • 2.9 Key Market Highlights by Deployment
  • 2.10 Key Market Highlights by Mode

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Single-Molecule Real-Time Sequencing
    • 4.1.2 Nanopore Sequencing
    • 4.1.3 Synthetic Long Read Sequencing
    • 4.1.4 Others
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Instruments
    • 4.2.2 Consumables
    • 4.2.3 Software
    • 4.2.4 Others
  • 4.3 Market Size & Forecast by Services (2020-2035)
    • 4.3.1 Sequencing Services
    • 4.3.2 Bioinformatics Services
    • 4.3.3 Others
  • 4.4 Market Size & Forecast by Technology (2020-2035)
    • 4.4.1 SMRT Sequencing
    • 4.4.2 Nanopore Sequencing
    • 4.4.3 Others
  • 4.5 Market Size & Forecast by Application (2020-2035)
    • 4.5.1 Whole Genome Sequencing
    • 4.5.2 Epigenetics
    • 4.5.3 Transcriptomics
    • 4.5.4 Metagenomics
    • 4.5.5 Structural Variation Detection
    • 4.5.6 Others
  • 4.6 Market Size & Forecast by End User (2020-2035)
    • 4.6.1 Academic and Research Institutions
    • 4.6.2 Pharmaceutical and Biotechnology Companies
    • 4.6.3 Hospitals and Clinics
    • 4.6.4 Others
  • 4.7 Market Size & Forecast by Component (2020-2035)
    • 4.7.1 Hardware
    • 4.7.2 Software
    • 4.7.3 Others
  • 4.8 Market Size & Forecast by Process (2020-2035)
    • 4.8.1 Library Preparation
    • 4.8.2 Sequencing
    • 4.8.3 Data Analysis
    • 4.8.4 Others
  • 4.9 Market Size & Forecast by Deployment (2020-2035)
    • 4.9.1 On-Premise
    • 4.9.2 Cloud-Based
    • 4.9.3 Others
  • 4.10 Market Size & Forecast by Mode (2020-2035)
    • 4.10.1 Research Mode
    • 4.10.2 Clinical Mode
    • 4.10.3 Others

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Services
      • 5.2.1.4 Technology
      • 5.2.1.5 Application
      • 5.2.1.6 End User
      • 5.2.1.7 Component
      • 5.2.1.8 Process
      • 5.2.1.9 Deployment
      • 5.2.1.10 Mode
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Services
      • 5.2.2.4 Technology
      • 5.2.2.5 Application
      • 5.2.2.6 End User
      • 5.2.2.7 Component
      • 5.2.2.8 Process
      • 5.2.2.9 Deployment
      • 5.2.2.10 Mode
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Services
      • 5.2.3.4 Technology
      • 5.2.3.5 Application
      • 5.2.3.6 End User
      • 5.2.3.7 Component
      • 5.2.3.8 Process
      • 5.2.3.9 Deployment
      • 5.2.3.10 Mode
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Services
      • 5.3.1.4 Technology
      • 5.3.1.5 Application
      • 5.3.1.6 End User
      • 5.3.1.7 Component
      • 5.3.1.8 Process
      • 5.3.1.9 Deployment
      • 5.3.1.10 Mode
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Services
      • 5.3.2.4 Technology
      • 5.3.2.5 Application
      • 5.3.2.6 End User
      • 5.3.2.7 Component
      • 5.3.2.8 Process
      • 5.3.2.9 Deployment
      • 5.3.2.10 Mode
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Services
      • 5.3.3.4 Technology
      • 5.3.3.5 Application
      • 5.3.3.6 End User
      • 5.3.3.7 Component
      • 5.3.3.8 Process
      • 5.3.3.9 Deployment
      • 5.3.3.10 Mode
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Services
      • 5.4.1.4 Technology
      • 5.4.1.5 Application
      • 5.4.1.6 End User
      • 5.4.1.7 Component
      • 5.4.1.8 Process
      • 5.4.1.9 Deployment
      • 5.4.1.10 Mode
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Services
      • 5.4.2.4 Technology
      • 5.4.2.5 Application
      • 5.4.2.6 End User
      • 5.4.2.7 Component
      • 5.4.2.8 Process
      • 5.4.2.9 Deployment
      • 5.4.2.10 Mode
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Services
      • 5.4.3.4 Technology
      • 5.4.3.5 Application
      • 5.4.3.6 End User
      • 5.4.3.7 Component
      • 5.4.3.8 Process
      • 5.4.3.9 Deployment
      • 5.4.3.10 Mode
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Services
      • 5.4.4.4 Technology
      • 5.4.4.5 Application
      • 5.4.4.6 End User
      • 5.4.4.7 Component
      • 5.4.4.8 Process
      • 5.4.4.9 Deployment
      • 5.4.4.10 Mode
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Services
      • 5.4.5.4 Technology
      • 5.4.5.5 Application
      • 5.4.5.6 End User
      • 5.4.5.7 Component
      • 5.4.5.8 Process
      • 5.4.5.9 Deployment
      • 5.4.5.10 Mode
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Services
      • 5.4.6.4 Technology
      • 5.4.6.5 Application
      • 5.4.6.6 End User
      • 5.4.6.7 Component
      • 5.4.6.8 Process
      • 5.4.6.9 Deployment
      • 5.4.6.10 Mode
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Services
      • 5.4.7.4 Technology
      • 5.4.7.5 Application
      • 5.4.7.6 End User
      • 5.4.7.7 Component
      • 5.4.7.8 Process
      • 5.4.7.9 Deployment
      • 5.4.7.10 Mode
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Services
      • 5.5.1.4 Technology
      • 5.5.1.5 Application
      • 5.5.1.6 End User
      • 5.5.1.7 Component
      • 5.5.1.8 Process
      • 5.5.1.9 Deployment
      • 5.5.1.10 Mode
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Services
      • 5.5.2.4 Technology
      • 5.5.2.5 Application
      • 5.5.2.6 End User
      • 5.5.2.7 Component
      • 5.5.2.8 Process
      • 5.5.2.9 Deployment
      • 5.5.2.10 Mode
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Services
      • 5.5.3.4 Technology
      • 5.5.3.5 Application
      • 5.5.3.6 End User
      • 5.5.3.7 Component
      • 5.5.3.8 Process
      • 5.5.3.9 Deployment
      • 5.5.3.10 Mode
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Services
      • 5.5.4.4 Technology
      • 5.5.4.5 Application
      • 5.5.4.6 End User
      • 5.5.4.7 Component
      • 5.5.4.8 Process
      • 5.5.4.9 Deployment
      • 5.5.4.10 Mode
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Services
      • 5.5.5.4 Technology
      • 5.5.5.5 Application
      • 5.5.5.6 End User
      • 5.5.5.7 Component
      • 5.5.5.8 Process
      • 5.5.5.9 Deployment
      • 5.5.5.10 Mode
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Services
      • 5.5.6.4 Technology
      • 5.5.6.5 Application
      • 5.5.6.6 End User
      • 5.5.6.7 Component
      • 5.5.6.8 Process
      • 5.5.6.9 Deployment
      • 5.5.6.10 Mode
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Services
      • 5.6.1.4 Technology
      • 5.6.1.5 Application
      • 5.6.1.6 End User
      • 5.6.1.7 Component
      • 5.6.1.8 Process
      • 5.6.1.9 Deployment
      • 5.6.1.10 Mode
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Services
      • 5.6.2.4 Technology
      • 5.6.2.5 Application
      • 5.6.2.6 End User
      • 5.6.2.7 Component
      • 5.6.2.8 Process
      • 5.6.2.9 Deployment
      • 5.6.2.10 Mode
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Services
      • 5.6.3.4 Technology
      • 5.6.3.5 Application
      • 5.6.3.6 End User
      • 5.6.3.7 Component
      • 5.6.3.8 Process
      • 5.6.3.9 Deployment
      • 5.6.3.10 Mode
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Services
      • 5.6.4.4 Technology
      • 5.6.4.5 Application
      • 5.6.4.6 End User
      • 5.6.4.7 Component
      • 5.6.4.8 Process
      • 5.6.4.9 Deployment
      • 5.6.4.10 Mode
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Services
      • 5.6.5.4 Technology
      • 5.6.5.5 Application
      • 5.6.5.6 End User
      • 5.6.5.7 Component
      • 5.6.5.8 Process
      • 5.6.5.9 Deployment
      • 5.6.5.10 Mode

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 Pacific Biosciences
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Oxford Nanopore Technologies
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Genapsys
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 Stratos Genomics
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 Element Biosciences
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 Quantum- Si
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 Dovetail Genomics
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Genome Transcriptome Facility of Bordeaux
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Seq LL
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 Bionano Genomics
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 Tecan Genomics
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 Arima Genomics
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 10x Genomics
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 Gencove
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Twist Bioscience
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 Bio Skryb Genomics
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 Nu GEN Technologies
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 Longas Technologies
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 Loop Genomics
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis
  • 8.20 Base Genomics
    • 8.20.1 Overview
    • 8.20.2 Product Summary
    • 8.20.3 Financial Performance
    • 8.20.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us